Obligasi 1BMY
Berikut ini adalah daftar obligasi korporasi BRISTOL-MYERS SQUIBB. Investor sering memilih obligasi perusahaan karena stabilitasnya yang lebih baik di saat pasar bergejolak. Pelajari harga, imbal hasil, dan statistik mereka lainnya dan temukan investasi yang dapat diandalkan.
Simbol | YTM % | Volume | Harga % | Kupon % | Tanggal Jatuh Tempo | Jumlah yang belum dibayar | Nilai nominal | Jumlah denominasi minimum | Penerbit |
|---|---|---|---|---|---|---|---|---|---|
| BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,27% | 5 K | 88,00% | 5,25% | 2043-08-15 | 4,064 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
 BMY.GCBristol-Myers Squibb Company 6.875% 01-AUG-2097 | 6,02% | 30 K | 119,38% | 6,88% | 2097-08-01 | 62,417 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 5,95% | 40 K | 87,86% | 5,00% | 2045-08-15 | 15,709 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,92% | 290 K | 97,64% | 5,70% | 2040-10-15 | 2,299 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 5,89% | 100 K | 78,85% | 4,35% | 2047-11-15 | 13,567 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122EC8BRIST.MYERS 23/63 | 5,83% | 0 | 110,47% | 6,40% | 2063-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EL8BRIST.MYERS 24/64 | 5,71% | 0 | 98,95% | 5,65% | 2064-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 5,67% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,204 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122EB0BRIST.MYERS 23/53 | 5,66% | 0 | 109,33% | 6,25% | 2053-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EK0BRIST.MYERS 24/54 | 5,58% | 0 | 99,49% | 5,55% | 2054-02-22 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EJ3BRIST.MYERS 24/44 | 5,47% | 0 | 100,35% | 5,50% | 2044-02-22 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009251Bristol-Myers Squibb Company 4.35% 15-NOV-2047 | 5,45% | 8,158 M | 84,39% | 4,35% | 2047-11-15 | 1,236 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BRMGBRISTOL-MYERS 13/44 | 5,45% | 0 | 88,04% | 4,50% | 2044-03-01 | 341,52 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009252Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 5,43% | 160 K | 94,28% | 5,00% | 2045-08-15 | 741,723 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007349Bristol-Myers Squibb Company 5.25% 15-AUG-2043 | 5,39% | 80 K | 98,24% | 5,25% | 2043-08-15 | 218,373 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 5,39% | 50 K | 90,21% | 4,63% | 2044-05-15 | 3,691 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BMY5007348Bristol-Myers Squibb Company 5.7% 15-OCT-2040 | 5,39% | 94 K | 103,50% | 5,70% | 2040-10-15 | 151,011 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009250Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 5,37% | 4,73 M | 88,20% | 4,55% | 2048-02-20 | 1,235 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009253Bristol-Myers Squibb Company 4.625% 15-MAY-2044 | 5,36% | 16 K | 90,60% | 4,63% | 2044-05-15 | 744,719 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009254Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 5,35% | 6,605 M | 83,58% | 4,25% | 2049-10-26 | 3,749 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DV7BRIST.MYERS 22/42 | 5,32% | 0 | 79,01% | 3,55% | 2042-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DW5BRIST.MYERS 22/52 | 5,32% | 0 | 74,40% | 3,70% | 2052-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122AP3BRISTOL-MYERS 2036 | 5,32% | 0 | 105,09% | 5,88% | 2036-11-15 | 279,22 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DX3BRIST.MYERS 22/62 | 5,31% | 0 | 73,63% | 3,90% | 2062-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY3883364Bristol-Myers Squibb Company 3.25% 01-AUG-2042 | 5,29% | 366 K | 75,38% | 3,25% | 2042-08-01 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5754772Bristol-Myers Squibb Company FRN 20-FEB-2026 | 5,27% | 624 K | 100,34% | 5,55% | 2026-02-20 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY.GNBristol-Myers Squibb Company 6.125% 01-MAY-2038 | 5,26% | 142 K | 108,65% | 6,13% | 2038-05-01 | 219,255 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007343Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 5,25% | 2,662 M | 88,10% | 4,13% | 2039-06-15 | 1,996 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DR6BRIST.MYERS 20/40 | 5,25% | 0 | 67,35% | 2,35% | 2040-11-13 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DS4BRIST.MYERS 20/50 | 5,15% | 0 | 59,50% | 2,55% | 2050-11-13 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EH7BRIST.MYERS 24/34 | 5,12% | 0 | 100,61% | 5,20% | 2034-02-22 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DZ8BRIST.MYERS 23/33 | 5,09% | 0 | 105,95% | 5,90% | 2033-11-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5,00% | 50 K | 95,66% | 3,45% | 2027-11-15 | 16,548 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122DU9BRIST.MYERS 22/32 | 4,95% | 0 | 87,58% | 2,95% | 2032-03-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DY1BRIST.MYERS 23/31 | 4,94% | 0 | 104,34% | 5,75% | 2031-02-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EG9BRIST.MYERS 24/31 | 4,91% | 0 | 101,01% | 5,10% | 2031-02-22 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,80% | 100 K | 97,29% | 3,90% | 2028-02-20 | 43,838 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122EF1BRIST.MYERS 24/29 | 4,74% | 0 | 100,64% | 4,90% | 2029-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007342Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | 4,70% | 823 K | 94,50% | 3,40% | 2029-07-26 | 2,373 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007345Bristol-Myers Squibb Company 3.875% 15-AUG-2025 | 4,69% | 15,257 M | 99,20% | 3,88% | 2025-08-15 | 228,734 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BRMJBRISTOL-MYERS 17/27 | 4,68% | 0 | 96,90% | 3,25% | 2027-02-27 | 512,277 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5077468Bristol-Myers Squibb Company 1.45% 13-NOV-2030 | 4,66% | 3,742 M | 83,09% | 1,45% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007347Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | 4,61% | 1,188 M | 97,84% | 3,90% | 2028-02-20 | 1,45 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122ED6BRIST.MYERS 24/26 | 4,61% | 0 | 100,42% | 4,95% | 2026-02-20 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5077466Bristol-Myers Squibb Company 0.75% 13-NOV-2025 | 4,60% | 270 K | 96,24% | 0,75% | 2025-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EE4BRIST.MYERS 24/27 | 4,57% | 0 | 100,72% | 4,90% | 2027-02-22 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DP0BRIST.MYERS 20/27 | 4,55% | 0 | 90,39% | 1,13% | 2027-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007341Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 4,54% | 138 K | 97,96% | 3,20% | 2026-06-15 | 1,744 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007346Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | 4,43% | 152 K | 97,23% | 3,45% | 2027-11-15 | 517,675 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY.GBBristol-Myers Squibb Company 6.8% 15-NOV-2026 | 4,37% | 228 K | 104,65% | 6,80% | 2026-11-15 | 255,948 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. |
| XS122674851BRISTOL-MYERS 15/35 | 3,16% | 0 | 87,30% | 1,75% | 2035-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. |
| BMY4831828Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 2,64% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4933148Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 2,47% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4931963Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 2,47% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4831826Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 2,30% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BRMHBRISTOL-MYERS 15/25 | 1,93% | 0 | 99,08% | 1,00% | 2025-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. |
| BMY4831822Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 0,50% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,953 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4831824Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | −0,14% | 0 | 116,69% | 3,40% | 2029-07-26 | 26,556 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4945645Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | −1,15% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4926518Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | −1,37% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |